COGNITIVE & DECENTRALIZED HEALTHCARE TECHNOLOGIES

Vytalyx is a health technology company that plans to use AI to provide health professionals with access to intelligence and insights in context across multiple big data sources – all through decentralization, cryptography and utilization of blockchain.

WHAT WE DO

Vytalyx is developing an end-to-end AI for healthcare, open-source and enterprise, that aims to combine the best qualities of humans and machines. Our goal is to provide innovative and intuitive AI solutions that understand clinical and wellness datasets, allowing health professionals to view and personalize relevant diagnoses, treatments, formulations and other results in context across multiple big data sources. We aim to provide health professionals with unfettered access to intelligence and data, which may help discover the most relevant relations between vast amounts of clinical and wellness entities. Our focus, making clinical and wellness decisions more informative and data-backed.

AI MODULES

Our goal is to develop various clinical and wellness AI modules in the following deployment areas.

Clinical Decision Support (CDS)

Blockchain enabled and AI-driven CDS deployments that may be used to personalize clinical diagnoses, treatment protocols and compounded drug formulations in various practice areas of medicine.

Patient Decision Support (PDS)

Blockchain enabled and AI-driven PDS deployments for patients that may increase patient-physician interaction and patient decision making, assisting clinicians in more efficient delivery of preventative care.

Evidenced-Based Medicine (EBM)

Blockchain enabled and AI-driven EBM deployments that may define clinically relevant questions, search for the best evidence, appraise the quality of the evidence, apply the evidence to clinical practice.

Wellness Decision Support (WDS)

Blockchain enabled and AI-driven WDS deployments that may be used to personalize nutrition plans, fitness programs and dietary supplement formulations based on patient biochemical entities and goals.

** WDS modules are not intended to diagnose, treat, cure or prevent any disease.

ADVANCING THE STANDARD OF CARE

Our planned AI aims to accelerate the development of a decentralized super-mind, helping the global healthcare community transcend into a more connected and intelligent modus operandi. Our AI is being designed as a peer-to-peer benefit-maximizing architecture where machine learning is federated.  This architecture may serve as a powerful collective human decision-making tool that has the potential to drive better decisions and improve health outcomes. Decentralization of our AI may be fully embraced by applying differentially private federated learning, a decentralized peer-to-peer machine learning model. Our planned AI is about helping health professionals maximize big data insights in order to discover the best clinical and wellness diagnoses and treatment options.

PRACTICE AREAS

Our goal is to develop various clinical and wellness AI modules in the following clinical and wellness practice areas.

hormone

Hormone Replacement Therapy

thyroid

Thyroid Replacement Therapy

cardiology

Cardiology | CHF

kidney

Kidney Disease Management

diabetes

Diabetes Management

neurology

Neurology

Sepsis

Sepsis

Pneumonia

Pneumonia

DIFFERENTIALLY PRIVATE FEDERATED LEARNING

Our planned AI intends to utilize differentially private federated learning. Federated learning is a form of decentralized peer-to-peer machine learning. Applying differential privacy to federated learning allows our blockchain, Fractalblock, to train machine learning models using another party’s data without the other party explicitly sharing data or knowing the other party’s data or intellectual property.

Rather than using a centralized machine learning architecture, federated learning brings an AI algorithm to the individual data source and uses the data to update the AI algorithm. By using federated learning models, numerous doctors and patients within our ecosystem may collaborate and learn more efficiently.

OUR AI

Unlike artificial intelligence, which may involve little to no human-machine intercommunication, augmented intelligence is information technology that may be codified to mimic human cognitive functions and may supplement and support human cognition, thinking and analysis, but leaves the human at the center of human-machine interaction.  Augmented intelligence is fundamentally about making smarter and more informed decisions that better simulate, understand and model human decision making, thought, processes and views.

 

Augmented Intelligence

Augmented Intelligence

Federated Learning

Federated Learning

Big Data Analytics

Big Data Analytics

Blockchain

Blockchain

PERSONALIZED HEALTH

AI

AI INPUTS

The Vytalyx AI

TARGET AI STATS

0
Target No. of Data Inputs
0
Target No. of Anonymized Medical Records
0
Target No. of Data Sources
0
Target No. of Biomarkers Analyzed

WHO ARE WE?

We are a group of entrepreneurs and executives who have started and developed numerous companies. From management to advisors, we have assembled a team of seasoned professionals with a ballistic focus on creating innovation for the world.

MANAGEMENT TEAM

David A. Granzotti
Co-Founder & Chief Executive Officer

Dr. Andre S. Granzotti MD
Co-Founder & Chief Medical Officer

John Hartwig
Chief Operating Officer

Jennifer Tanguy
Chief Marketing Officer

Jeffrey P. Heller
Chief Financial Officer

David P. Valenti
Chief Legal Officer

Gary Pike
Chief Blockchain Officer

Jonathan Tarr
Chief Chemist

BOARD OF DIRECTORS

David A. Granzotti
Chairman

Dr. Andre S. Granzotti MD
Director

Dave Wentz
Director

TECHNOLOGY DEVELOPERS

Ben Lamm
Artificial Intelligence

John Fremont
AI & Blockchain

Will Womble
Artificial Intelligence & Technology

Marc Boudria
Artificial Intelligence Engineer

Drew Lipman
AI, Blockchain & Data Science

Travis Turner
Technology & Software Engineering

Matt Jafee
Technology & Software Engineering

Alain Bernstein
Technology & Software Engineering

Todd Gruben
Technology & Software Engineering

Cody Soyland
Technology & Software Engineering

Jonathan Spillman
Technology & Operations

H.O. MayCotte
Database Technology

TECHNOLOGY ADVISORS

Dale Sanders
EHR Data Warehousing

Dr. Asad Mahmood
AI & Blockchain

Josef Schaible
Blockchain

Yemo Adeyemo
Blockchain

Mattan Lurie
Blockchain

MEDICAL & SCIENCE ADVISORS

Dr. Rand McClain DO
Sports & Regenerative Medicine

Dr. Steve Sobol MD
Thyroid & ENT Medicine

Dr. Jordan Youngerman MD
Medicine

Heidi Sexton APN, ACNP
Medicine

Dr. Mihnea Dumitrescu MD
Pain Management

Magda Orzechowska
Genetics & Medical Biotechnology

Dinesh Madhyastha
Genetics & Bioinformatics

Ryon Talbot
Fitness & Exercise Science

PHARMACEUTICAL ADVISORS

Robert Matje
Pharmaceutical Operations

Russell Teague
Pharmaceutical Operations

David Burgoss
Design, Validation & Qualification

Ray Wheeler
Pharmaceutical Project Engineering

Lois Horne
Quality Assurance & Regulatory Affairs

George Harmon
Pharmaceutical Operations

Lance Lercher RPh
Pharmacy Management

Hayden Gharibyar
Compounding Pharmacy Operations

LEGAL ADVISORS

Edward Allera, Esq
Legal (FDA, DEA, Pharmaceuticals)

Rick Collins, Esq
Legal (FDA, DEA, Dietary Supplements)

Lee Rosebush, Esq
Legal (FDA, DEA, 503B Compounding)

Eric Madigan, Esq
Legal (Patents & Trademarks)

John Rivas, Esq
Legal (Stark, CPM, Anti-Kickback)

MEDIA

Austin Business Journal
Cision
Yahoo
Medium

CONTACT US

For inquiries, please enter your email below.